Drug Safety White Paper Will "Trigger" Action Plans - AMA/NPSF Proposal
Executive Summary
The National Patient Safety Foundation at the American Medical Association will develop a white paper on pharmaceutical safety to address roles and responsibilities of all components of the health care system, according to a proposal submitted to FDA.
You may also be interested in...
FDA Drug Safety Teaching Modules Being Developed For MD, RN Students
FDA is constructing teaching modules to educate medical, pharmacy and nursing students about drug development and drug safety issues, FDA Office of Training and Communication Director Nancy Smith announced at an FDA roundtable discussion with health professional organizations March 23.
ADRs In The News: Redux, Rezulin And Lupron Receiving Unwanted Attention
The handling of adverse event reports that led to the withdrawal of Wyeth-Ayerst's Redux (fenfluramine) is expected to be the subject of a "60 Minutes II" segment scheduled to air Feb. 3.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011